This company has a blockbuster drug which it will bring to market sooner and less expensively than originally anticipated and these issues will be discussed in the conference call at 5 pm.
This is an opportunity to buy more shares, looking forward to NDA filing.
Best of all, ACAD has narrowed their lost since last year.
thank you!!! Finally someone who knows something exactly earnings won't move this stock!!!!! It's the blockbuster drug that will
I'm listening to the call now, everything sounds great. Quite exciting.